Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose.

Elisa MarabottoDiego Ferone Afscin Djahandideh SheijaniLara VeraSebastiano ZiolaEdoardo Vincenzo SavarinoGiorgia BodiniManuele FurnariPatrizia ZentilinVincenzo SavarinoMassimo GiustiFabiola Andrea Navarro RojasMarcello BagnascoManuela AlbertelliEdoardo Giovanni Giannini

Published in: Nutrients (2022)

the prevalence of LI in patients with HT was 58.6%, not different from global prevalence of LI. In the absence of other gastrointestinal disorders, LI seems not to be a major cause of LT4 malabsorption and does not affect the LT4 required dose in HT patients.

Keyphrases

risk factors
end stage renal disease
ion batteries
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
solid state
patient reported outcomes